NO834777L - Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivaterInfo
- Publication number
- NO834777L NO834777L NO834777A NO834777A NO834777L NO 834777 L NO834777 L NO 834777L NO 834777 A NO834777 A NO 834777A NO 834777 A NO834777 A NO 834777A NO 834777 L NO834777 L NO 834777L
- Authority
- NO
- Norway
- Prior art keywords
- pyridyl
- alkyl
- pyridine
- oxo
- methyl
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims description 91
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 14
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 51
- -1 methylenedioxy group Chemical group 0.000 claims description 39
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 125000004076 pyridyl group Chemical group 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 125000006239 protecting group Chemical group 0.000 claims description 8
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical group OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims description 7
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 3
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 claims 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 153
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 111
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 83
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 72
- 239000000203 mixture Substances 0.000 description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 45
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 44
- 238000010992 reflux Methods 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- 238000001704 evaporation Methods 0.000 description 36
- 230000008020 evaporation Effects 0.000 description 36
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 32
- 239000000460 chlorine Substances 0.000 description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 25
- 239000000284 extract Substances 0.000 description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 17
- 229910000104 sodium hydride Inorganic materials 0.000 description 17
- 239000012312 sodium hydride Substances 0.000 description 17
- 238000001816 cooling Methods 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- 229960001340 histamine Drugs 0.000 description 16
- BYNUACNSLSSKPU-UHFFFAOYSA-N n'-methyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound NCCCN(C)C1=CC=CC=N1 BYNUACNSLSSKPU-UHFFFAOYSA-N 0.000 description 13
- KWBSLRQDOHBJPQ-UHFFFAOYSA-N n-[5-[(6-methylpyridin-3-yl)methyl]-6-oxo-1h-pyrimidin-2-yl]nitramide Chemical compound C1=NC(C)=CC=C1CC1=CN=C(N[N+]([O-])=O)NC1=O KWBSLRQDOHBJPQ-UHFFFAOYSA-N 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 239000012259 ether extract Substances 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- MTSFOMHMPQMRCU-UHFFFAOYSA-N n'-propyl-n'-pyridin-2-ylbutane-1,4-diamine Chemical compound NCCCCN(CCC)C1=CC=CC=N1 MTSFOMHMPQMRCU-UHFFFAOYSA-N 0.000 description 10
- HOYGMPDDEVYMNG-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(Cl)C=C1 HOYGMPDDEVYMNG-UHFFFAOYSA-N 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- CNDAFPBECHAXDU-UHFFFAOYSA-N n'-pyridin-2-ylpropane-1,3-diamine Chemical compound NCCCNC1=CC=CC=N1 CNDAFPBECHAXDU-UHFFFAOYSA-N 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 8
- JHNDAQPKGDFQIQ-UHFFFAOYSA-N n'-propyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound NCCCN(CCC)C1=CC=CC=N1 JHNDAQPKGDFQIQ-UHFFFAOYSA-N 0.000 description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 239000000739 antihistaminic agent Substances 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000005557 antagonist Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000002026 chloroform extract Substances 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- RTNAJFYRBGURSJ-UHFFFAOYSA-N n'-benzyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C=1C=CC=NC=1N(CCCN)CC1=CC=CC=C1 RTNAJFYRBGURSJ-UHFFFAOYSA-N 0.000 description 5
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 5
- 125000006308 propyl amino group Chemical group 0.000 description 5
- XEVZHZYMRVTGTR-UHFFFAOYSA-N 5-[(4-fluorophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(F)C=C1 XEVZHZYMRVTGTR-UHFFFAOYSA-N 0.000 description 4
- LYTMGJCSPRGACH-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound C1=CC(OC)=CC=C1CC1=CN=C(SC)NC1=O LYTMGJCSPRGACH-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- LQVVPVYSYDCLFY-UHFFFAOYSA-N n'-(3-methylpyridin-2-yl)propane-1,3-diamine Chemical compound CC1=CC=CN=C1NCCCN LQVVPVYSYDCLFY-UHFFFAOYSA-N 0.000 description 4
- RAJSAPSERUGCBT-UHFFFAOYSA-N n'-pyridin-2-ylbutane-1,4-diamine Chemical compound NCCCCNC1=CC=CC=N1 RAJSAPSERUGCBT-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- PZSISEFPCYMBDL-UHFFFAOYSA-N 2-bromo-3-methylpyridine Chemical compound CC1=CC=CN=C1Br PZSISEFPCYMBDL-UHFFFAOYSA-N 0.000 description 3
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- CJPNRBHTHRCYQX-UHFFFAOYSA-N n'-(5-bromopyridin-2-yl)propane-1,3-diamine Chemical compound NCCCNC1=CC=C(Br)C=N1 CJPNRBHTHRCYQX-UHFFFAOYSA-N 0.000 description 3
- JTMRNELAKPDUOH-UHFFFAOYSA-N n'-methyl-n'-(3-methylpyridin-2-yl)propane-1,3-diamine Chemical compound NCCCN(C)C1=NC=CC=C1C JTMRNELAKPDUOH-UHFFFAOYSA-N 0.000 description 3
- TYHXIJJQIJKFSO-UHFFFAOYSA-N n'-pyridin-2-ylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=N1 TYHXIJJQIJKFSO-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 2
- VRSPCJIWIFSYCR-UHFFFAOYSA-N 2-[3-(n-pyridin-2-ylanilino)propyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCN(C=1N=CC=CC=1)C1=CC=CC=C1 VRSPCJIWIFSYCR-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- BQWYVFWLLFIBSX-UHFFFAOYSA-N 5-(cyclohexylmethyl)-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1CCCCC1 BQWYVFWLLFIBSX-UHFFFAOYSA-N 0.000 description 2
- AYDCHIJZVBAQTI-UHFFFAOYSA-N 5-[(4-fluorophenyl)methyl]-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=C(F)C=C1 AYDCHIJZVBAQTI-UHFFFAOYSA-N 0.000 description 2
- CVIHRBGDGMLCBS-UHFFFAOYSA-N 5-[(4-hydroxyphenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(O)C=C1 CVIHRBGDGMLCBS-UHFFFAOYSA-N 0.000 description 2
- UZUZDPZGHPRBDE-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-2-[3-[propyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCNC(NC1=O)=NC=C1CC1=CC=C(OC)C=C1 UZUZDPZGHPRBDE-UHFFFAOYSA-N 0.000 description 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 206010012434 Dermatitis allergic Diseases 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 125000006309 butyl amino group Chemical group 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- AECVAARGMKOYMI-UHFFFAOYSA-N n'-(4-methylpyridin-2-yl)propane-1,3-diamine Chemical compound CC1=CC=NC(NCCCN)=C1 AECVAARGMKOYMI-UHFFFAOYSA-N 0.000 description 2
- LKWNAUWCXCHQJG-UHFFFAOYSA-N n'-(5-bromopyridin-2-yl)-n'-methylpropane-1,3-diamine Chemical compound NCCCN(C)C1=CC=C(Br)C=N1 LKWNAUWCXCHQJG-UHFFFAOYSA-N 0.000 description 2
- VRHUIBMCEZNVAW-UHFFFAOYSA-N n'-(6-methylpyridin-2-yl)propane-1,3-diamine Chemical compound CC1=CC=CC(NCCCN)=N1 VRHUIBMCEZNVAW-UHFFFAOYSA-N 0.000 description 2
- UQWRIYBBAXXGQG-UHFFFAOYSA-N n'-[(2-chlorophenyl)methyl]-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C=1C=CC=NC=1N(CCCN)CC1=CC=CC=C1Cl UQWRIYBBAXXGQG-UHFFFAOYSA-N 0.000 description 2
- ZCTQLAGNFLRTBS-UHFFFAOYSA-N n'-[(3-chlorophenyl)methyl]-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C=1C=CC=NC=1N(CCCN)CC1=CC=CC(Cl)=C1 ZCTQLAGNFLRTBS-UHFFFAOYSA-N 0.000 description 2
- JVVSYNUUVZAGHV-UHFFFAOYSA-N n'-[(4-chlorophenyl)methyl]-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C=1C=CC=NC=1N(CCCN)CC1=CC=C(Cl)C=C1 JVVSYNUUVZAGHV-UHFFFAOYSA-N 0.000 description 2
- GXVWAPSUGRGEOE-UHFFFAOYSA-N n'-[(4-methoxyphenyl)methyl]-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C1=CC(OC)=CC=C1CN(CCCN)C1=CC=CC=N1 GXVWAPSUGRGEOE-UHFFFAOYSA-N 0.000 description 2
- BZLBQHIXQZIFJP-UHFFFAOYSA-N n'-benzyl-n'-(5-bromopyridin-2-yl)propane-1,3-diamine Chemical compound C=1C=C(Br)C=NC=1N(CCCN)CC1=CC=CC=C1 BZLBQHIXQZIFJP-UHFFFAOYSA-N 0.000 description 2
- OWPDARIZDGKRHW-UHFFFAOYSA-N n'-benzyl-n'-pyridin-2-ylbutane-1,4-diamine Chemical compound C=1C=CC=NC=1N(CCCCN)CC1=CC=CC=C1 OWPDARIZDGKRHW-UHFFFAOYSA-N 0.000 description 2
- ALHRAUKTLRQUEV-UHFFFAOYSA-N n'-benzyl-n'-pyridin-2-ylethane-1,2-diamine Chemical compound C=1C=CC=NC=1N(CCN)CC1=CC=CC=C1 ALHRAUKTLRQUEV-UHFFFAOYSA-N 0.000 description 2
- PDWRPFYRISKDFJ-UHFFFAOYSA-N n'-methyl-n'-(4-methylpyridin-2-yl)propane-1,3-diamine Chemical compound NCCCN(C)C1=CC(C)=CC=N1 PDWRPFYRISKDFJ-UHFFFAOYSA-N 0.000 description 2
- ASZWMMKASJYATF-UHFFFAOYSA-N n'-methyl-n'-(6-methylpyridin-2-yl)propane-1,3-diamine Chemical compound NCCCN(C)C1=CC=CC(C)=N1 ASZWMMKASJYATF-UHFFFAOYSA-N 0.000 description 2
- HKJRDZGKAHYDIL-UHFFFAOYSA-N n'-methyl-n'-pyridin-2-ylbutane-1,4-diamine Chemical compound NCCCCN(C)C1=CC=CC=N1 HKJRDZGKAHYDIL-UHFFFAOYSA-N 0.000 description 2
- HWDGMJIXPWQDCM-UHFFFAOYSA-N n'-methyl-n'-pyridin-2-ylethane-1,2-diamine Chemical compound NCCN(C)C1=CC=CC=N1 HWDGMJIXPWQDCM-UHFFFAOYSA-N 0.000 description 2
- RKJPTHCVPPIDHI-UHFFFAOYSA-N n'-phenyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound C=1C=CC=NC=1N(CCCN)C1=CC=CC=C1 RKJPTHCVPPIDHI-UHFFFAOYSA-N 0.000 description 2
- PZXOXBZZZIOKDI-UHFFFAOYSA-N n-[6-oxo-5-(pyridin-4-ylmethyl)-1h-pyrimidin-2-yl]nitramide Chemical compound O=C1NC(N[N+](=O)[O-])=NC=C1CC1=CC=NC=C1 PZXOXBZZZIOKDI-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 125000005544 phthalimido group Chemical group 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-UCVXFZOQSA-N 1-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@H]1[C@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UCVXFZOQSA-N 0.000 description 1
- BASMANVIUSSIIM-UHFFFAOYSA-N 1-chloro-2-(chloromethyl)benzene Chemical compound ClCC1=CC=CC=C1Cl BASMANVIUSSIIM-UHFFFAOYSA-N 0.000 description 1
- DDGRAFHHXYIQQR-UHFFFAOYSA-N 1-chloro-3-(chloromethyl)benzene Chemical compound ClCC1=CC=CC(Cl)=C1 DDGRAFHHXYIQQR-UHFFFAOYSA-N 0.000 description 1
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 description 1
- ZHXUWDPHUQHFOV-UHFFFAOYSA-N 2,5-dibromopyridine Chemical compound BrC1=CC=C(Br)N=C1 ZHXUWDPHUQHFOV-UHFFFAOYSA-N 0.000 description 1
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
- PBKJWZFEQMVUQK-UHFFFAOYSA-N 2-[2-[benzyl(pyridin-2-yl)amino]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCN(C=1N=CC=CC=1)CC1=CC=CC=C1 PBKJWZFEQMVUQK-UHFFFAOYSA-N 0.000 description 1
- MUTZLUBINMOFKQ-UHFFFAOYSA-N 2-[3-[(2-chlorophenyl)methyl-pyridin-2-ylamino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC=CC=1)CC1=CC=CC=C1Cl MUTZLUBINMOFKQ-UHFFFAOYSA-N 0.000 description 1
- CHLPQLPXERGBET-UHFFFAOYSA-N 2-[3-[(3-chlorophenyl)methyl-pyridin-2-ylamino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC=CC=1)CC1=CC=CC(Cl)=C1 CHLPQLPXERGBET-UHFFFAOYSA-N 0.000 description 1
- MFRCQGRIUQGEEC-UHFFFAOYSA-N 2-[3-[benzyl(pyridin-2-yl)amino]propylamino]-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one Chemical compound N=1C=C(CC=2C=CN=CC=2)C(=O)NC=1NCCCN(C=1N=CC=CC=1)CC1=CC=CC=C1 MFRCQGRIUQGEEC-UHFFFAOYSA-N 0.000 description 1
- PDXXVYLGUDFDJR-UHFFFAOYSA-N 2-[3-[benzyl(pyridin-2-yl)amino]propylamino]-5-[(4-chlorophenyl)methyl]-1h-pyrimidin-6-one Chemical compound C1=CC(Cl)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC=CC=1)CC1=CC=CC=C1 PDXXVYLGUDFDJR-UHFFFAOYSA-N 0.000 description 1
- DVTLCGTZJSCXKE-UHFFFAOYSA-N 2-[3-[benzyl(pyridin-2-yl)amino]propylamino]-5-[(5,6-dimethylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound N1=C(C)C(C)=CC(CC=2C(NC(NCCCN(CC=3C=CC=CC=3)C=3N=CC=CC=3)=NC=2)=O)=C1 DVTLCGTZJSCXKE-UHFFFAOYSA-N 0.000 description 1
- AUWMKLLZTLIJCV-UHFFFAOYSA-N 2-[3-[benzyl(pyridin-2-yl)amino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC=CC=1)CC1=CC=CC=C1 AUWMKLLZTLIJCV-UHFFFAOYSA-N 0.000 description 1
- UHPICSGCKIPOCO-UHFFFAOYSA-N 2-[3-[benzyl-(5-bromopyridin-2-yl)amino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC(Br)=CC=1)CC1=CC=CC=C1 UHPICSGCKIPOCO-UHFFFAOYSA-N 0.000 description 1
- BYCHYAONULGRBZ-UHFFFAOYSA-N 2-[3-[butyl(pyridin-2-yl)amino]propylamino]-5-[(4-chlorophenyl)methyl]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCCC)CCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 BYCHYAONULGRBZ-UHFFFAOYSA-N 0.000 description 1
- VDNIWDQTXXAPSO-UHFFFAOYSA-N 2-[3-[methyl(pyridin-2-yl)amino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(C)N=C1 VDNIWDQTXXAPSO-UHFFFAOYSA-N 0.000 description 1
- JHACSLRPCHPAKJ-UHFFFAOYSA-N 2-[3-[methyl-(3-methylpyridin-2-yl)amino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound N=1C=CC=C(C)C=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(C)N=C1 JHACSLRPCHPAKJ-UHFFFAOYSA-N 0.000 description 1
- LAWBKYABIMZUHD-UHFFFAOYSA-N 2-[3-[methyl-(6-methylpyridin-2-yl)amino]propylamino]-5-[(6-methylpyridin-3-yl)methyl]-1h-pyrimidin-6-one Chemical compound C=1C=CC(C)=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(C)N=C1 LAWBKYABIMZUHD-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- OHDFRLVOAYTIDT-UHFFFAOYSA-N 2-[4-[butyl(pyridin-2-yl)amino]butylamino]-5-[(4-chlorophenyl)methyl]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCCC)CCCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 OHDFRLVOAYTIDT-UHFFFAOYSA-N 0.000 description 1
- OOOYAEIVORDXNM-UHFFFAOYSA-N 2-[4-[propyl(pyridin-2-yl)amino]butylamino]-5-(pyridin-4-ylmethyl)-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=NC=C1 OOOYAEIVORDXNM-UHFFFAOYSA-N 0.000 description 1
- LSZMVESSGLHDJE-UHFFFAOYSA-N 2-bromo-4-methylpyridine Chemical compound CC1=CC=NC(Br)=C1 LSZMVESSGLHDJE-UHFFFAOYSA-N 0.000 description 1
- SOHDPICLICFSOP-UHFFFAOYSA-N 2-bromo-6-methylpyridine Chemical compound CC1=CC=CC(Br)=N1 SOHDPICLICFSOP-UHFFFAOYSA-N 0.000 description 1
- VKVZRJQBZJLLFO-UHFFFAOYSA-N 2-methylsulfanyl-5-(2-phenylethyl)-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CCC1=CC=CC=C1 VKVZRJQBZJLLFO-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WHEDELKAGAPEOL-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-ylmethyl)-2-[3-[propyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound N=1C=C(CC=2C=C3OCOC3=CC=2)C(=O)NC=1NCCCN(CCC)C1=CC=CC=N1 WHEDELKAGAPEOL-UHFFFAOYSA-N 0.000 description 1
- OCXFENHBQQUCAK-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-ylmethyl)-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound N=1C=C(CC=2C=C3OCOC3=CC=2)C(=O)NC=1NCCCCN(CCC)C1=CC=CC=N1 OCXFENHBQQUCAK-UHFFFAOYSA-N 0.000 description 1
- TVLWBMFWHQWENK-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-ylmethyl)-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(OCO2)C2=C1 TVLWBMFWHQWENK-UHFFFAOYSA-N 0.000 description 1
- UKBSOFSYNDZWJZ-UHFFFAOYSA-N 5-(cyclohexylmethyl)-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1CCCCC1 UKBSOFSYNDZWJZ-UHFFFAOYSA-N 0.000 description 1
- HMKMIGZPYHSFSK-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=CC=C1Cl HMKMIGZPYHSFSK-UHFFFAOYSA-N 0.000 description 1
- PHICNKHKQHRGQT-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=CC=C1Cl PHICNKHKQHRGQT-UHFFFAOYSA-N 0.000 description 1
- HIAYAUXDZYADTR-UHFFFAOYSA-N 5-[(2-methoxypyridin-4-yl)methyl]-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=NC(OC)=C1 HIAYAUXDZYADTR-UHFFFAOYSA-N 0.000 description 1
- RMIVGCYFHRMBGR-UHFFFAOYSA-N 5-[(2-oxo-1h-pyridin-4-yl)methyl]-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=NC(O)=C1 RMIVGCYFHRMBGR-UHFFFAOYSA-N 0.000 description 1
- IBVGWTAHYHBDPG-UHFFFAOYSA-N 5-[(3,4-dichlorophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C(Cl)=C1 IBVGWTAHYHBDPG-UHFFFAOYSA-N 0.000 description 1
- CUDPTJIZUFTCSL-UHFFFAOYSA-N 5-[(3,4-dichlorophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(Cl)C(Cl)=C1 CUDPTJIZUFTCSL-UHFFFAOYSA-N 0.000 description 1
- SMFXTBAMACLPJE-UHFFFAOYSA-N 5-[(3-chlorophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=CC(Cl)=C1 SMFXTBAMACLPJE-UHFFFAOYSA-N 0.000 description 1
- KTXBMRWMKZZVKR-UHFFFAOYSA-N 5-[(3-chlorophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=CC(Cl)=C1 KTXBMRWMKZZVKR-UHFFFAOYSA-N 0.000 description 1
- PUCUNEOYLKEYDB-UHFFFAOYSA-N 5-[(4-bromophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(Br)C=C1 PUCUNEOYLKEYDB-UHFFFAOYSA-N 0.000 description 1
- QJMVDJZIJRAEBV-UHFFFAOYSA-N 5-[(4-bromophenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(Br)C=C1 QJMVDJZIJRAEBV-UHFFFAOYSA-N 0.000 description 1
- BULSJQCJKNHEOL-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[2-[methyl(pyridin-2-yl)amino]ethylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 BULSJQCJKNHEOL-UHFFFAOYSA-N 0.000 description 1
- MXEWRVWACLHCBZ-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[3-[ethyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CC)CCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 MXEWRVWACLHCBZ-UHFFFAOYSA-N 0.000 description 1
- ZBFZWNHOVQZZEQ-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 ZBFZWNHOVQZZEQ-UHFFFAOYSA-N 0.000 description 1
- UUQVUFPWWODFND-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[3-[propyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 UUQVUFPWWODFND-UHFFFAOYSA-N 0.000 description 1
- GPAKBFSOFSRJCZ-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[4-[methyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 GPAKBFSOFSRJCZ-UHFFFAOYSA-N 0.000 description 1
- IRLAHZHNYGBULO-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2-[4-[propyl(pyridin-2-yl)amino]butylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=C(Cl)C=C1 IRLAHZHNYGBULO-UHFFFAOYSA-N 0.000 description 1
- WPFCQTDBKWIDTF-UHFFFAOYSA-N 5-[(4-fluorophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(F)C=C1 WPFCQTDBKWIDTF-UHFFFAOYSA-N 0.000 description 1
- GEOCVFKNOWDLIM-UHFFFAOYSA-N 5-[(4-fluorophenyl)methyl]-2-[3-[propyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(CCC)CCCNC(NC1=O)=NC=C1CC1=CC=C(F)C=C1 GEOCVFKNOWDLIM-UHFFFAOYSA-N 0.000 description 1
- BVSDMWKHJFDZRL-UHFFFAOYSA-N 5-[(4-hydroxy-3-nitrophenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(O)C([N+]([O-])=O)=C1 BVSDMWKHJFDZRL-UHFFFAOYSA-N 0.000 description 1
- ILLRMEMSEBPLOE-UHFFFAOYSA-N 5-[(4-hydroxyphenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(O)C=C1 ILLRMEMSEBPLOE-UHFFFAOYSA-N 0.000 description 1
- SIZNYUQMNFPHNS-UHFFFAOYSA-N 5-[(4-methylphenyl)methyl]-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=C(C)C=C1 SIZNYUQMNFPHNS-UHFFFAOYSA-N 0.000 description 1
- PBIQRBBUIDCZBF-UHFFFAOYSA-N 5-[(4-methylphenyl)methyl]-2-methylsulfanyl-1h-pyrimidin-6-one Chemical compound O=C1NC(SC)=NC=C1CC1=CC=C(C)C=C1 PBIQRBBUIDCZBF-UHFFFAOYSA-N 0.000 description 1
- OAHSPIAEYZHAFI-UHFFFAOYSA-N 5-[(6-methylpyridin-3-yl)methyl]-2-[3-(n-pyridin-2-ylanilino)propylamino]-1h-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCCN(C=1N=CC=CC=1)C1=CC=CC=C1 OAHSPIAEYZHAFI-UHFFFAOYSA-N 0.000 description 1
- AGEPNNFEOVONID-UHFFFAOYSA-N 5-benzyl-2-[3-[methyl(pyridin-2-yl)amino]propylamino]-1h-pyrimidin-6-one Chemical compound C=1C=CC=NC=1N(C)CCCNC(NC1=O)=NC=C1CC1=CC=CC=C1 AGEPNNFEOVONID-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229940122236 Histamine receptor antagonist Drugs 0.000 description 1
- HUYWAWARQUIQLE-UHFFFAOYSA-N Isoetharine Chemical compound CC(C)NC(CC)C(O)C1=CC=C(O)C(O)=C1 HUYWAWARQUIQLE-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- GIKRWONNSXTWEZ-SPIKMXEPSA-N OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=NC(OC)=C1 Chemical compound OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1N(CCC)CCCCNC(NC1=O)=NC=C1CC1=CC=NC(OC)=C1 GIKRWONNSXTWEZ-SPIKMXEPSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 125000004171 alkoxy aryl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 125000005002 aryl methyl group Chemical group 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- IIQFIDKGTDXLBU-UHFFFAOYSA-N benzyl thiohypochlorite Chemical compound ClSCC1=CC=CC=C1 IIQFIDKGTDXLBU-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- GHWVXCQZPNWFRO-UHFFFAOYSA-N butane-2,3-diamine Chemical compound CC(N)C(C)N GHWVXCQZPNWFRO-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 229960001268 isoetarine Drugs 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- NRCLTOJLQHLVRZ-UHFFFAOYSA-N n'-butyl-n'-pyridin-2-ylbutane-1,4-diamine Chemical compound NCCCCN(CCCC)C1=CC=CC=N1 NRCLTOJLQHLVRZ-UHFFFAOYSA-N 0.000 description 1
- MATSICZCARNAFK-UHFFFAOYSA-N n'-butyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound CCCCN(CCCN)C1=CC=CC=N1 MATSICZCARNAFK-UHFFFAOYSA-N 0.000 description 1
- ZQVQEEHXAPPYRB-UHFFFAOYSA-N n'-ethyl-n'-pyridin-2-ylpropane-1,3-diamine Chemical compound NCCCN(CC)C1=CC=CC=N1 ZQVQEEHXAPPYRB-UHFFFAOYSA-N 0.000 description 1
- HIPZITWPRXNZKU-UHFFFAOYSA-N n-(5-benzyl-6-oxo-1h-pyrimidin-2-yl)nitramide Chemical compound O=C1NC(N[N+](=O)[O-])=NC=C1CC1=CC=CC=C1 HIPZITWPRXNZKU-UHFFFAOYSA-N 0.000 description 1
- DYSDJZQYNYDJBU-UHFFFAOYSA-N n-[5-[(2-methoxypyridin-4-yl)methyl]-6-oxo-1h-pyrimidin-2-yl]nitramide Chemical compound C1=NC(OC)=CC(CC=2C(NC(N[N+]([O-])=O)=NC=2)=O)=C1 DYSDJZQYNYDJBU-UHFFFAOYSA-N 0.000 description 1
- WCCXSTMOFAXKAF-UHFFFAOYSA-N n-[5-[(5,6-dimethylpyridin-3-yl)methyl]-6-oxo-1h-pyrimidin-2-yl]nitramide Chemical compound N1=C(C)C(C)=CC(CC=2C(NC(N[N+]([O-])=O)=NC=2)=O)=C1 WCCXSTMOFAXKAF-UHFFFAOYSA-N 0.000 description 1
- HUDSSSKDWYXKGP-UHFFFAOYSA-N n-phenylpyridin-2-amine Chemical compound C=1C=CC=NC=1NC1=CC=CC=C1 HUDSSSKDWYXKGP-UHFFFAOYSA-N 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- ZNZJJSYHZBXQSM-UHFFFAOYSA-N propane-2,2-diamine Chemical compound CC(C)(N)N ZNZJJSYHZBXQSM-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8236638 | 1982-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO834777L true NO834777L (no) | 1984-06-25 |
Family
ID=10535202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO834777A NO834777L (no) | 1982-12-23 | 1983-12-22 | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4547506A (ko) |
| EP (1) | EP0113572B1 (ko) |
| JP (1) | JPS59130285A (ko) |
| KR (1) | KR840006992A (ko) |
| AU (1) | AU2274683A (ko) |
| DE (1) | DE3375574D1 (ko) |
| DK (1) | DK584683A (ko) |
| ES (1) | ES528310A0 (ko) |
| FI (1) | FI834736A (ko) |
| GR (1) | GR79735B (ko) |
| IL (1) | IL70496A0 (ko) |
| NO (1) | NO834777L (ko) |
| PT (1) | PT77856B (ko) |
| ZA (1) | ZA839529B (ko) |
| ZW (1) | ZW27483A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0112707B1 (en) * | 1982-12-23 | 1987-11-04 | Smith Kline & French Laboratories Limited | Aminopyrimidinone derivatives as histamine h1-antagonists |
| CA1286297C (en) * | 1985-06-13 | 1991-07-16 | George S. Sach | Pyridine derivatives |
| GB8601816D0 (en) * | 1986-01-25 | 1986-02-26 | Smith Kline French Lab | Pyridine derivatives |
| ZA9756B (en) * | 1996-01-16 | 1997-07-17 | Warner Lambert Co | Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines |
| US7426961B2 (en) * | 2002-09-03 | 2008-09-23 | Bj Services Company | Method of treating subterranean formations with porous particulate materials |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3535328A (en) * | 1967-09-01 | 1970-10-20 | Exxon Research Engineering Co | Certain substituted aminothioethoxy pyridines |
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| US4218452A (en) * | 1975-10-02 | 1980-08-19 | Smith Kline & French Laboratories Limited | Substituted 4-pyrimidone compounds, compositions and methods of use |
| US4154834A (en) * | 1975-12-29 | 1979-05-15 | Smith Kline & French Laboratories Limited | Substituted isocytosines having histamine H2 -antagonist activity |
| US4227000A (en) * | 1978-04-11 | 1980-10-07 | Smith Kline & French Laboratories Limited | Intermediates in the process for making histamine antagonists |
| US4255428A (en) * | 1979-03-24 | 1981-03-10 | Smith Kline & French Laboratories Limited | 5-(Hydroxypyridylalkyl)-4-pyrimidones |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
-
1983
- 1983-12-19 EP EP83307721A patent/EP0113572B1/en not_active Expired
- 1983-12-19 DE DE8383307721T patent/DE3375574D1/de not_active Expired
- 1983-12-19 PT PT77856A patent/PT77856B/pt unknown
- 1983-12-19 DK DK584683A patent/DK584683A/da not_active Application Discontinuation
- 1983-12-20 IL IL70496A patent/IL70496A0/xx unknown
- 1983-12-20 ZW ZW274/83A patent/ZW27483A1/xx unknown
- 1983-12-20 US US06/563,495 patent/US4547506A/en not_active Expired - Fee Related
- 1983-12-21 AU AU22746/83A patent/AU2274683A/en not_active Abandoned
- 1983-12-22 GR GR73337A patent/GR79735B/el unknown
- 1983-12-22 ES ES528310A patent/ES528310A0/es active Granted
- 1983-12-22 NO NO834777A patent/NO834777L/no unknown
- 1983-12-22 ZA ZA839529A patent/ZA839529B/xx unknown
- 1983-12-22 FI FI834736A patent/FI834736A/fi not_active Application Discontinuation
- 1983-12-22 JP JP58243047A patent/JPS59130285A/ja active Pending
- 1983-12-23 KR KR1019830006151A patent/KR840006992A/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK584683D0 (da) | 1983-12-19 |
| IL70496A0 (en) | 1984-03-30 |
| EP0113572A3 (en) | 1985-08-28 |
| JPS59130285A (ja) | 1984-07-26 |
| ES8504771A1 (es) | 1985-05-01 |
| FI834736A0 (fi) | 1983-12-22 |
| DE3375574D1 (en) | 1988-03-10 |
| ES528310A0 (es) | 1985-05-01 |
| GR79735B (ko) | 1984-10-31 |
| ZA839529B (en) | 1984-08-29 |
| EP0113572B1 (en) | 1988-02-03 |
| US4547506A (en) | 1985-10-15 |
| DK584683A (da) | 1984-06-24 |
| FI834736A (fi) | 1984-06-24 |
| PT77856B (en) | 1986-04-16 |
| AU2274683A (en) | 1984-06-28 |
| PT77856A (en) | 1984-01-01 |
| EP0113572A2 (en) | 1984-07-18 |
| KR840006992A (ko) | 1984-12-04 |
| ZW27483A1 (en) | 1985-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1089860A (en) | Pyridinyl-2(1h)-pyridinones and preparation | |
| NO845228L (no) | Kinolinforbindelser. | |
| US20080107608A1 (en) | 5-Substituted-2-Arylpyridines | |
| US4548940A (en) | Pyridylaminoalkylaminopyrimidones useful as histamine H1 -antagonists | |
| NO834778L (no) | Fremgangsmaate for fremstilling av pyridinderivater for anvendelse som histamin h1-antagonister | |
| SK70899A3 (en) | 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors | |
| US4486434A (en) | Histamine H1 -antagonists | |
| KR20120097425A (ko) | 4-페녹시-니코틴아미드 또는 4-페녹시-피리미딘-5-카복스아미드 화합물 | |
| CH631981A5 (en) | Process for preparing novel derivatives of pyrimid-4-one and pyrimid-4-thione, and their salts with acids | |
| NO834777L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater | |
| HU180081B (en) | Process for producing hystamine antagonic 2-amino-pirimidone derivatives | |
| CZ280569B6 (cs) | 4-Substituované dihydropyrido/4,3-d/pyrimidiny, způsob jejich přípravy a farmaceutické kompozice, které je obsahují | |
| US4764519A (en) | 3-hydroxypyridines | |
| NO831642L (no) | Kinazolinderivater. | |
| EP0107914B1 (en) | Aminopyrimidinone derivatives useful as histamine h1-antagonists | |
| NZ208956A (en) | Pyrimidone derivatives | |
| EP0115132B1 (en) | Pyrimidone derivatives | |
| CA1178960A (en) | Pyrimidone derivatives | |
| GB2101599A (en) | Derivatives of 4-pyrimidone | |
| Sach et al. | Histamine H 1-antagonists | |
| JPS5993074A (ja) | ピリミドン誘導体 | |
| JPS59110693A (ja) | ピリドン誘導体 |